India's specialty chemicals sector is entering an important phase of growth driven by China Plus One sourcing and green chemistry initiatives. According to reports from The Financial Express, demand is rising across industries including pharmaceuticals, agrochemicals, food processing, personal care and home care. The opportunity is expanding further as global companies diversify their supply chains beyond China, with India offering a large manufacturing base, technical expertise and competitive production costs. New opportunities are emerging in green solvents, biodegradable surfactants and bio-based polymers. According to IBEF, India's green chemicals market is expected to grow at more than 10% annually and cross $15 billion by 2027. The fluorochemicals market, valued at $25.3 billion in 2024 and projected to reach $36 billion by 2033, is shifting towards high-value specialty applications, with India's domestic market expected to grow at a CAGR of 10.24% for 2024-2029. As per recent reports, electric vehicles use significantly more fluoropolymers like polyvinylidene fluoride (PVDF) in batteries, cables, and thermal management systems compared to traditional models, while semiconductor manufacturing relies on high-purity fluorinated gases for etching and fabrication.
Laxmi Organic delivered exceptional Q1 FY27 results with revenue climbing 40% year-over-year to ₹9,683 million and EBITDA surging 272% to ₹1,143 million. The company's EBITDA margin improved by 740 basis points to 11.8%, while gross margins expanded 660 basis points to 37.5%. Profit after tax grew 216% to ₹677 million with PAT margins rising 390 basis points to 7.0%. The strong performance was attributed to higher realizations and operating leverage, which more than offset increased energy and freight costs. Supply chain agility ensured timely availability of feedstock at competitive prices. The Essentials business posted 50% revenue growth to ₹7,265 million benefiting from strong ethyl acetate spreads, while the Specialties business grew 17% to ₹2,418 million with EBITDA contribution increasing from 11% in Q1 FY26 to 28% in Q1 FY27. The company operates 400 kT+ capacity across four manufacturing sites serving 700+ active customers in 55+ countries with 25% green power usage and an asset base of approximately ₹21,000 million.
Galaxy Surfactants trades at an EV/EBITDA ratio of 13.8x, significantly below its five-year median of 17.6x. For FY26, consolidated revenue rose 24.3% year-on-year to ₹5,248 crore, but net profit fell 12.3% to ₹267 crore. The company, incorporated in 1986, manufactures performance surfactants and specialty care products used in consumer-centric home and personal care products. According to The Financial Express, the weakness was largely linked to external disruptions including the West Asia conflict affecting shipping routes and feedstock availability. The company's Egypt facility was particularly affected, with raw materials delayed at transshipment points and outbound dispatches disrupted, leaving the plant largely idle during March.
Atul delivered impressive Q1 FY27 results with consolidated revenue rising 25% year-on-year to ₹1,848 crore and net profit nearly doubling to ₹254 crore. The company trades at an EV/EBITDA ratio of 14.0x, well below its five-year median of 24.1x. The growth was led by the performance and other chemicals segment, which saw revenue rise 33.8% to ₹1,427 crore. However, as reported by The Financial Express, the company faces ongoing challenges from Chinese competition and weak export pricing. Revenue from markets outside India grew 7% in FY26, while the company continues to work on local sourcing and downstream products to reduce dependence on Chinese imports.
Vinati Organics trades at an EV/EBITDA ratio of 18.2x, significantly below its five-year median of 32.4x. The company's Q1 FY27 results showed consolidated revenue rising 28.4% to ₹696 crore, but net profit growth cooled to 4.5% to ₹109 crore due to higher operating costs. According to The Financial Express, demand for ATBS, the company's largest product contributing around 35% of FY26 revenue, had softened from October 2025 due to customer destocking. The company maintains a debt-free status with treasury funds of around ₹190 crore and holds a strong global position in acrylamido tertiary butyl sulfonic acid (ATBS).
